Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-12-017347
Filing Date
2012-03-27
Accepted
2012-03-27 13:09:05
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v306345_10k.htm 10-K 1321588
2 EXHIBIT 23.1 v306345_ex23-1.htm EX-23.1 2379
3 EXHIBIT 31.1 v306345_ex31-1.htm EX-31.1 6893
4 EXHIBIT 31.2 v306345_ex31-2.htm EX-31.2 7020
5 EXHIBIT 32.1 v306345_ex32-1.htm EX-32.1 4402
6 EXHIBIT 32.2 v306345_ex32-2.htm EX-32.2 4606
7 GRAPHIC pg26.jpg GRAPHIC 44211
  Complete submission text file 0001144204-12-017347.txt   4811591

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT rprx-20111231.xml EX-101.INS 556551
9 XBRL TAXONOMY EXTENSION SCHEMA rprx-20111231.xsd EX-101.SCH 21967
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rprx-20111231_cal.xml EX-101.CAL 39572
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rprx-20111231_def.xml EX-101.DEF 144115
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20111231_lab.xml EX-101.LAB 192170
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20111231_pre.xml EX-101.PRE 167638
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

EIN.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15281 | Film No.: 12716526
SIC: 2836 Biological Products, (No Diagnostic Substances)